SIMPL, which stands for Signal Integration by the Mitogen-activated Protein kinase (MAPK) Pathway, is a protein that in humans is encoded by the SIMPL gene. This protein acts as a modulator of transcriptional response within the MAPK signaling pathway, which is a critical cascade in cellular biology that transmits molecular signals from the cell membrane to the nucleus.The MAPK pathway is involved in a wide array of cellular processes, including growth, differentiation, and response to stress. It is made up of a series of kinase enzymes that activate one another in a specific sequence, leading to the phosphorylation and activation of downstream targets, including transcription factors that regulate gene expression.
SIMPL itself is not a kinase but rather a nuclear protein that interacts with the MAPK pathway components. It has been found to function as an adaptor or scaffold protein, facilitating the interaction between the MAPKs and their target transcription factors in the nucleus. Specifically, SIMPL has been shown to interact with tumor necrosis factor-alpha (TNF-alpha) and modulate the activity of transcription factor NF-kappaB, which plays a pivotal role in immune and inflammatory responses.By influencing the NF-kappaB pathway, SIMPL can impact the transcription of genes that are involved in immune and inflammatory responses, cell survival, and apoptosis. Dysregulation of NF-kappaB has been linked to various pathological conditions, including cancer, inflammatory and autoimmune diseases, and viral infections, which highlights the potential significance of SIMPL in disease processes.
| Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inibitore della p38 MAP chinasi, influenza indirettamente l'IRAK1BP1 agendo sulle vie di segnalazione a valle correlate all'IL-1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Un inibitore di MEK, che può influenzare indirettamente IRAK1BP1 modulando le vie di segnalazione ERK/MAPK. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Un inibitore di JNK, potenzialmente in grado di influenzare IRAK1BP1 attraverso le vie delle proteine chinasi attivate dallo stress. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Un inibitore di PI3K, che potrebbe influenzare l'attività di IRAK1BP1 indirettamente attraverso la via di segnalazione di AKT. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Un altro inibitore di PI3K, potenzialmente in grado di modulare IRAK1BP1 influenzando la segnalazione PI3K/AKT. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Un inibitore di mTOR, potenzialmente in grado di influenzare l'attività di IRAK1BP1 indirettamente attraverso le vie di segnalazione di mTOR. | ||||||